Yahoo Sports reporter Pete Thamel discusses the Razorbacks nailbiter victory against 15 Oral Roberts.
Yahoo Sports reporter Pete Thamel discusses the Razorbacks nailbiter victory against 15 Oral Roberts.
The online personal lender announced on Twitter that it has refiled its S-4 with the Securities and Exchange Commission.
Stock futures pointed to a higher open Friday morning, steadying after selling off sharply on Thursday following a report that President Joe Biden was eyeing a proposal to increase the capital gains tax rate on wealthy individuals.
The Jack Brooks Foundation is hosting an inaugural award ceremony featuring a frank discussion about voting and elections with award recipients Lina Hidalgo and Arnold Schwarzenegger, online and open to the public free of charge on Tuesday, April 27, at 12 noon CDT. The host of the panel discussion, "Elections and the Future of Voting," will be CBS News Correspondent Omar Villafranca. The panel discussion promises to be a lively encounter between two very determined leaders who found creative ways to help Americans vote. Interested viewers can register and access a link to view the event at https://link.jackbrooksfoundation.org/events.
American Express earnings unexpectedly rose, helped by a release of credit loss reserves, but the Dow Jones giant missed on revenue. AXP stock fell.
The dress itself, the dress's backstory, Zendaya in the dress...it's all a lot to process.
Sanctuary Wealth, home to the next generation of elite advisors, is enhancing its position in the San Antonio market with the addition of JDK Wealth Advisors as the latest team to choose its partnered independence business model. The four-person team, managing and advising on approximately $400 million in client assets, is the seventh firm to join Sanctuary this year, and the second in San Antonio. The firm is led by Managing Partners Brad Johnson, Randy Daniels and Jonathan Klug, who collectively spent more than 30 years with Merrill Lynch, ably assisted by Director of Operations Martha Ortega.
FORM 8.3 IRISH TAKEOVER PANELDISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Name of person dealing (Note 1)State Street Global Advisors & AffiliatesCompany dealt inWillis Towers Watson plc.Class of relevant security to which the dealings being disclosed relate (Note 2)US$0.000304635 ordinary sharesDate of dealing22nd April 2021 2. INTERESTS AND SHORT POSITIONS (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) LongShort Number(%)Number(%)(1) Relevant securities6,384,201 4.95012% (2) Derivatives (other than options)N/A (3) Options and agreements to purchase/sellN/A Total6,384,201 4.95012% (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of relevant security:LongShort Number(%)Number(%)(1) Relevant securitiesN/A (2) Derivatives (other than options)N/A (3) Options and agreements to purchase/sellN/A TotalN/A 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/saleNumber of relevant securitiesPrice per unit (Note 5)Purchase100234.14Purchase12233.15Purchase50233.15Purchase1,672233.15Purchase290233.15Purchase18233.15Purchase27233.15Purchase332233.15Purchase115233.15Purchase63233.15Sale1,520233.15Sale6,080233.15Sale2,128233.15Sale464233.15Sale3,364233.15Sale45233.15 (b) Derivatives transactions (other than options transactions) Product name, e.g. CFDNature of transaction (Note 6)Number of relevant securities (Note 7)Price per unit (Note 5)N/A (c) Options transactions in respect of existing relevant securities (i) Writing, selling, purchasing or varying Product name, e.g. call optionWriting, selling, purchasing varying etc.Number of securities to which the option relates (Note 7)Exercise priceType, e.g. American, European etc.Expiry dateOption money paid/received per unit (Note 5)N/A (ii) Exercising Product name, e.g. call optionNumber of securitiesExercise price per unit (Note 5)N/A (d) Other dealings (including transactions in respect of new securities) (Note 4) Nature of transaction (Note 8)DetailsPrice per unit (if applicable) (Note 5)N/A 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.N/A Is a Supplemental Form 8 attached? (Note 9)NO Date of disclosure23rd April 2021 Contact nameLionel ColacoTelephone number 020 33956098If a connected EFM, name of offeree/offeror with which connectedN/AIf a connected EFM, state nature of connection (Note 10)N/A
This week, PSEG Nuclear's Hope Creek Generating Station marked another uninterrupted 18-month production cycle and entered a planned refueling and maintenance outage after operators safely removed the unit from the regional power grid.
Cathie Wood's ARK Invest ETFs are some of the hottest ETFs after 2020's huge gains. Five ARK Invest stocks to buy and watch include Coinbase and Tesla.
The company faced challenges last year in expanding the label of its only drug. Will 2021 bring different results?
In this article we will take a look at the 10 best tech stocks to invest in for long-term. You can skip our comprehensive analysis of the technology industry and go directly to the 5 Best Tech Stocks to Invest in For Long-Term. The previous year was a somber one for many in the world. […]
Elevation Financial Group, a senior and multifamily affordable housing provider, announces the successful disposition of Elevation Real Property Fund VI asset, Serenity Apartments at Huntsville. The 231-unit multifamily community sold for $13.25 million.
Turkey's membership negotiations to join the European Union should be formally suspended if Ankara continues on its autocratic track, EU lawmakers said on Friday, saying a decision was urgent as basic freedoms in the country are curtailed. Lawmakers in the European Parliament's Foreign Affairs Committee voted 49 in favour, four against and with 14 abstentions on their report on Turkey's EU candidacy, which now goes to the full plenary next month and, if accepted, becomes the parliament's official position. After years of stalemate on Turkey's bid to join the world's biggest trading bloc, negotiations launched in 2005 have come to a halt, although they are not officially suspended.
Hungary's government is walking back two controversial pieces of legislation that targeted foreign universities and civil society groups after they were struck down by the European Union's top court. A draft bill submitted to Hungary's parliament this week would amend a 2017 law on higher education which effectively forced one of the country's top schools, Central European University (CEU), to leave the country. In a ruling last year, the European Court of Justice found the legislation was incompatible with EU law.
The Old Trafford giants were among the 12 founding members of the controversial breakaway competition.
The star hurt himself during a challenge.
Helixmith, a gene therapy company, announced today that three abstracts have been accepted for poster presentations at the virtual 2021 American Academy of Pain Medicine Annual Meeting to be held April 23 – 25, 2021.
Through clinical trial meta-analysis and real-world evidence, Eli Lilly and Company's (NYSE: LLY) Taltz® (ixekizumab) demonstrated greater success in key measured treatment outcomes compared to other biologics in adults with moderate to severe plaque psoriasis. In the first one-year network meta-analysis based on area under the curve, Taltz showed numerically greater cumulative benefits on completely clear skin over one year compared to seven other biologics, as measured by Psoriasis Area Severity Index (PASI) 100. In three real-world analyses of U.S. claims data ranging from one to three years, patients treated with Taltz stayed on treatment longer, were more adherent to the prescription and had more days on monotherapy compared to the other biologics studied. These results are being presented virtually at the American Academy of Dermatology's Virtual Meeting Experience (AAD VMX), April 23-25, 2021.
Through new analyses of BREEZE-AD5 Phase 3 clinical trial data and an extended safety analysis across multiple trials, Eli Lilly and Company (NYSE: LLY) and Incyte's (NASDAQ:INCY) OLUMIANT® (baricitinib) 2-mg tablet taken once daily showed improvement in key measured treatment outcomes compared to placebo, and helped further characterize the long-term safety profile in adults with moderate to severe atopic dermatitis (AD). In one BREEZE-AD5 analysis, OLUMIANT provided concurrent improvements in the severity and extent of AD, other key symptoms and quality of life as early as one week, as measured by percent change from baseline compared to placebo. In a separate BREEZE-AD5 analysis, adults with AD on 10-50% of their bodies at baseline who were treated with OLUMIANT showed significant improvements in the severity and extent of disease compared to placebo. In the integrated safety analysis of eight AD studies of OLUMIANT, there were no increases in rates for treatment-emergent adverse events, serious adverse events or serious infections with long-term OLUMIANT therapy compared to the placebo-controlled period. These results are being presented virtually at the American Academy of Dermatology's Virtual Meeting Experience (AAD VMX), April 23-25, 2021.
ROSEMONT, Ill., April 23, 2021 (GLOBE NEWSWIRE) -- The AAD VMX 2021, a virtual meeting experience taking place April 23-25, will feature the latest information on skin, hair and nails, presented by world-renowned experts in the field of dermatology. Board-Certified Dermatologist Warns Consumers About the Dangers of Skin Bleaching to Achieve a Lighter Complexion Despite the potential dangers of skin bleaching products, the global market for skin lighteners last year was estimated at $8.6 billion. With the market projected to reach $12.3 billion by 2027, a board-certified dermatologist from the American Academy of Dermatology expresses concern about this growing trend and the unintended health consequences of pursuing lighter skin at any cost. Read more. Board-Certified Dermatologist Shares How Visible Light Impacts the Skin Visible light is all around us. From nature’s sunlight to artificial light sources from ceiling lights, our phones, computer screens and TVs, we may be exposed to more visible light than ever before, but what does that mean for our skin? Read more. New Research Focuses on a Growing Pandemic Problem – "Zoom Dysmorphia" During the pandemic, there was a shift to remote work, and demand for video conferencing increased. A board-certified dermatologist shares findings revealing how increased exposure on camera, combined with the distorting effects of front-facing cameras, is leading patients to think negatively about their appearance and seek cosmetic care — a new phenomenon she calls “Zoom Dysmorphia.” Read more. To view this release in a media-rich format, go to: https://aad.new-media-release.com/2021/aadvmx/ CONTACTS: Nicole Dobkin (847) 240-1746 email@example.com Julie Landmesser (847) 240-1714 JLandmesser@aad.org